Perftoran( ® ) Inhibits Hypoxia-Associated Resistance in Lung Cancer Cells to Carboplatin

Perftoran(®) (perfluorodecalin) is an oxygen carrier, and carboplatin is a common chemotherapy drug used worldwide for lung cancer treatment. Hypoxia is one of the factors that induce resistance of lung cancer cells to carboplatin. This study explored the role of Perftoran(®), as an oxygen carrier,...

Descripción completa

Detalles Bibliográficos
Autores principales: Gamal-Eldeen, Amira M., Alrehaili, Amani A., Alharthi, Afaf, Raafat, Bassem M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987772/
https://www.ncbi.nlm.nih.gov/pubmed/35401227
http://dx.doi.org/10.3389/fphar.2022.860898

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987772/
https://www.ncbi.nlm.nih.gov/pubmed/35401227
http://dx.doi.org/10.3389/fphar.2022.860898

Ejemplares similares